ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag politics disease medicine

A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Updated Mar 8
A healthcare worker holds up three syringes with clear medicine
To Booster or Not: Scientists and Regulators Debate
Jef Akst | Sep 16, 2021 | 7 min read
President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.
Guts and Glory
Anna Azvolinsky | Apr 1, 2016 | 9 min read
An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
Antibody Alternatives
Paul Ko Ferrigno and Jane McLeod | Feb 1, 2016 | 10+ min read
Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.
The Surgisphere Scandal: What Went Wrong?
Catherine Offord | Oct 1, 2020 | 10+ min read
The high-profile retractions of two COVID-19 studies stunned the scientific community earlier this year and prompted calls for reviews of how science is conducted, published, and acted upon. The warning signs had been there all along.
Elias A. Zerhouni
Ted Agres | Jul 7, 2002 | 4 min read
In the mid-1980s, cardiologists faced a particularly vexing problem: how to measure, accurately and noninvasively, the thickness of heart tissue as it changed over time. Elias A. Zerhouni, a young radiology professor at Johns Hopkins School of Medicine, struggled over the issue with a small team of physicists. "One day, he walked into the room with this incredible smile on his face, like you would have if you made a great molecular discovery," recalls Myron Weisfeldt, director of Hopkins' Depart
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
What Budget Cuts Might Mean for US Science
Diana Kwon | Mar 21, 2017 | 5 min read
A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  
AIDS Researchers, Activists Wary Of Newspaper Article's Message
Steven Benowitz | Jun 9, 1996 | 10+ min read
Despite contrary suggestions, they say CDC's prevention efforts aimed toward general public were not wasted A recent article in the Wall Street Journal is causing concern in the AIDS research community. The article, titled "AIDS Fight Is Skewed By Federal Campaign Exaggerating Risks" (A. Bennett, A. Sharpe, May 1, 1996, page 1), contends that the federal Centers for Disease Control and Prevention (CDC) in Atlanta has distorted the public's perception of the potential for contracting AIDS with a

Run a Search

ADVERTISEMENT